Intuitive Surgical (NASDAQ:ISRG) EVP Myriam Curet Sells 125 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 125 shares of the company’s stock in a transaction on Wednesday, October 29th. The shares were sold at an average price of $543.00, for a total value of $67,875.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Myriam Curet also recently made the following trade(s):

• On Tuesday, October 28th, Myriam Curet sold 7,562 shares of Intuitive Surgical stock. The shares were sold at an average price of $548.43, for a total value of $4,147,227.66.

Intuitive Surgical Trading Down 1.4%

Shares of NASDAQ ISRG opened at $537.59 on Thursday. The business has a fifty day simple moving average of $461.96 and a 200 day simple moving average of $498.01. The firm has a market capitalization of $192.72 billion, a price-to-earnings ratio of 71.11, a PEG ratio of 5.01 and a beta of 1.61. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s revenue was up 22.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.84 earnings per share. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on ISRG shares. HSBC increased their price objective on Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. The Goldman Sachs Group increased their price objective on Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Royal Bank Of Canada set a $625.00 price objective on Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. BTIG Research increased their price objective on Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Finally, Daiwa Capital Markets increased their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $608.92.

Institutional Trading of Intuitive Surgical

Several large investors have recently made changes to their positions in the business. Grey Fox Wealth Advisors LLC bought a new stake in shares of Intuitive Surgical during the third quarter worth $111,000. Bank of Stockton grew its holdings in shares of Intuitive Surgical by 16.0% during the third quarter. Bank of Stockton now owns 1,427 shares of the medical equipment provider’s stock worth $638,000 after purchasing an additional 197 shares during the last quarter. Vaughan David Investments LLC IL grew its holdings in shares of Intuitive Surgical by 5.5% during the third quarter. Vaughan David Investments LLC IL now owns 773 shares of the medical equipment provider’s stock worth $346,000 after purchasing an additional 40 shares during the last quarter. Inscription Capital LLC grew its holdings in shares of Intuitive Surgical by 222.6% during the third quarter. Inscription Capital LLC now owns 2,226 shares of the medical equipment provider’s stock worth $996,000 after purchasing an additional 1,536 shares during the last quarter. Finally, Parsons Capital Management Inc. RI boosted its holdings in Intuitive Surgical by 11.0% in the third quarter. Parsons Capital Management Inc. RI now owns 2,103 shares of the medical equipment provider’s stock valued at $941,000 after acquiring an additional 208 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.